Dongho Shin

Chief Business Officer at MVRIX

Speaker

Dongho Shin is Chief Business Officer at MVRIX Co., Ltd., where he leads business development, strategic partnerships, IP transactions, and legal affairs. A U.S. attorney admitted in Washington, D.C., he previously served as Senior Counsel and later in business development leadership roles at ToolGen, gaining experience in CRISPR patent disputes and technology licensing. At MVRIX, he focuses on advancing global partnerships for the company’s Navibody™ targeted delivery platform, in vivo CAR-T programs, and recombinant botulinum toxin program.